Calcium antagonists: A new class of therapeutic agents.
A new class of therapeutic agents, sharing inhibition of the slow calcium channel, will soon be available to the American patient. Selective action of these agents upon the atrioventricular node, the smooth muscle of coronary and peripheral arteries, and the contractility of cardiac muscle opens new vistas in cardiovascular pharmacology. Early release of these agents by the Federal Drug Administration for general use is urged, based upon the already wide and successful experience in the European and South American continents.
Gunawan
Antonius
A
Clayton Foundation for Research Cardiovascular Laboratories and the Division of Cardiology of St. Luke's Episcopal Hospital and the Texas Heart Institute, Houston, Texas.
Massumi
Ali
A
Hall
Robert J.
RJ